Emergency vaccine response cut infectious disease deaths
Researchers believe that vaccinations stopped much bigger outbreaks of illnesses like Ebola, cholera and yellow fever.
The study also points to the significant economic benefits of vaccination programmes, which run into billions of dollars.
Researchers say this is the first comprehensive study to assess the impact of emergency vaccination programmes in response to the outbreak of five infectious diseases – Ebola, measles, cholera, yellow fever and meningitis.
They studied 210 different incidents from 2000 to 2023, covering 49 different countries. The vaccine roll-outs seem to have had an impressive impact, reducing deaths by nearly 60%.
The number of overall cases of these infections were also reduced by nearly 60%. The swift deployment of vaccines also appears to have halted wider outbreaks. There were economic benefits too – worth an estimated $32 billion. These benefits come mainly from averting deaths and years of life lost to disability.
But researchers believe this could be a significant underestimate of overall savings, as it doesn't take into account the costs of dealing with a wider outbreak, or the economic disruption caused by a more serious health emergency.
It's believed the 2014 Ebola outbreak, which occurred before the existence of an approved vaccine, is estimated to have cost West African countries alone more than $53 billion.
The study was backed by Gavi, the vaccine alliance, which was responsible for many of the programmes.
Dr Sania Nishtar, the organisation's CEO, says the study shows just how important quick and effective vaccine roll-outs can be.
"For the first time, we are able to comprehensively quantify the benefit, in human and economic terms, of deploying vaccines against outbreaks of some of the deadliest infectious diseases.
"This study demonstrates clearly the power of vaccines as a cost-effective counter-measure to the increasing risk the world faces from outbreaks.
"It also underscores the importance of fully funding Gavi, so it can continue to protect communities in the next five years to come."
Gavi is currently trying to secure a fresh round of funding in the face of global cuts to foreign aid.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
6 hours ago
- Zawya
Vaccination against cholera brings hope to more than 2 million Angolans
A new round of the oral vaccination campaign against cholera was officially launched this Saturday in the municipality of Cafunfo, Lunda Norte province, an initiative of the Angolan government, through the Ministry of Health, with the support of GAVI - Global Alliance for Vaccines, the World Health Organization (WHO), UNICEF, the European Union and other partners in the health sector. The campaign plans to vaccinate more than 2 million people in the most affected municipalities in the provinces of Cabinda, Kwanza Sul, Huíla, Lunda Norte, Namibe and Zaire - regions where there is currently active transmission of the disease. The campaign started simultaneously in all the provinces covered, with teams on the ground starting vaccination activities at fixed posts and through door-to-door visits. At the launch, the Minister of Health, Dr. Sílvia Lutucuta, called on everyone to get involved: 'Everyone has to take part in this war against cholera, we're almost there, there's just a little bit left and if we all work together we'll be able to get rid of cholera in Angola.' The minister also highlighted the strengthening of the response capacity thanks to the support of partners: "Through our partners, we managed to get around 1 million vaccines in the first and second rounds. Now we've got 2 million vaccines that will allow us to increase coverage and protect even more people." The vaccine used in this round is Euvichol-S, an oral, single-dose vaccine donated by Gavi and distributed via the international mechanism coordinated by the International Coordination Group (ICG). The campaign involves 942 vaccination teams, made up of vaccinators, mobilizers and supervisors, who will work at fixed posts and also through door-to-door visits. All people aged one year and over will be vaccinated, as part of an integrated response that includes epidemiological surveillance, access to drinking water, sanitation, risk communication and case management. During the ceremony, the WHO Representative in Angola, Dr. Indrajit Hazarika, highlighted the role of the vaccine in protecting communities, but recalled that it must be complemented by other structural measures: "The oral vaccine is a strong tool in our hands, in each campaign we stop the transmission of cholera by reinforcing the vital shield of protection for communities. But the vaccine alone is not enough, we must remain vigilant. The fight against cholera is also about sustainable investment in water, sanitation and hygiene. Only in this way will we cut cholera in the long term." In the beneficiary neighborhoods, the mood is hopeful. After months of fear and uncertainty, the arrival of the vaccine represents a concrete response and essential protection, especially for the most vulnerable families. Verónica Domingos Ferreira, who lives in the municipality of Kikombo, Kwanza Sul, was one of the people vaccinated. After seeing her neighbors fall ill months ago, she decided to seek information and protect her family. Today, she is relieved: "I'm very grateful. Today I got vaccinated and I vaccinated my children. This vaccine is a blessing. Now I feel that my family is better protected." With actions like this, Angola is strengthening its capacity to respond to outbreaks and reaffirming its commitment to the health and dignity of its communities. The campaign will continue in the coming days, with calls for the active participation of the entire population. Distributed by APO Group on behalf of World Health Organization (WHO) - Angola.
Sharjah 24
21 hours ago
- Sharjah 24
Emergency vaccine response cut infectious disease deaths
A similar number of infections are also thought to have been prevented. Researchers believe that vaccinations stopped much bigger outbreaks of illnesses like Ebola, cholera and yellow fever. The study also points to the significant economic benefits of vaccination programmes, which run into billions of dollars. Researchers say this is the first comprehensive study to assess the impact of emergency vaccination programmes in response to the outbreak of five infectious diseases – Ebola, measles, cholera, yellow fever and meningitis. They studied 210 different incidents from 2000 to 2023, covering 49 different countries. The vaccine roll-outs seem to have had an impressive impact, reducing deaths by nearly 60%. The number of overall cases of these infections were also reduced by nearly 60%. The swift deployment of vaccines also appears to have halted wider outbreaks. There were economic benefits too – worth an estimated $32 billion. These benefits come mainly from averting deaths and years of life lost to disability. But researchers believe this could be a significant underestimate of overall savings, as it doesn't take into account the costs of dealing with a wider outbreak, or the economic disruption caused by a more serious health emergency. It's believed the 2014 Ebola outbreak, which occurred before the existence of an approved vaccine, is estimated to have cost West African countries alone more than $53 billion. The study was backed by Gavi, the vaccine alliance, which was responsible for many of the programmes. Dr Sania Nishtar, the organisation's CEO, says the study shows just how important quick and effective vaccine roll-outs can be. "For the first time, we are able to comprehensively quantify the benefit, in human and economic terms, of deploying vaccines against outbreaks of some of the deadliest infectious diseases. "This study demonstrates clearly the power of vaccines as a cost-effective counter-measure to the increasing risk the world faces from outbreaks. "It also underscores the importance of fully funding Gavi, so it can continue to protect communities in the next five years to come." Gavi is currently trying to secure a fresh round of funding in the face of global cuts to foreign aid.
Gulf Today
a day ago
- Gulf Today
Emergency vaccines slash deaths by 60 per cent since 2000, reveals study
Emergency vaccination programmes – rolled out in response to outbreaks of five major diseases – are believed to have reduced deaths by around 60% over a period of 23 years, according to a new study. A similar number of infections are also thought to have been prevented. Researchers believe that vaccinations stopped much bigger outbreaks of illnesses like Ebola, cholera and yellow fever. The study also points to the significant economic benefits of vaccination programmes, which run into billions of dollars. According to BBC, researchers say this is the first comprehensive study to assess the impact of emergency vaccination programmes in response to the outbreak of five infectious diseases – Ebola, measles, cholera, yellow fever and meningitis. They studied 210 different incidents from 2000 to 2023, covering 49 different countries. The vaccine roll-outs seem to have had an impressive impact, reducing deaths by nearly 60%. The number of overall cases of these infections were also reduced by nearly 60%. The swift deployment of vaccines also appears to have halted wider outbreaks. There were economic benefits too – worth an estimated $32 billion. These benefits come mainly from averting deaths and years of life lost to disability. But researchers believe this could be a significant underestimate of overall savings, as it doesn't take into account the costs of dealing with a wider outbreak, or the economic disruption caused by a more serious health emergency. It's believed the 2014 Ebola outbreak, which occurred before the existence of an approved vaccine, is estimated to have cost West African countries alone more than $53 billion. The study was backed by Gavi, the vaccine alliance, which was responsible for many of the programmes. Dr Sania Nishtar, the organisation's CEO, says the study shows just how important quick and effective vaccine roll-outs can be. "For the first time, we are able to comprehensively quantify the benefit, in human and economic terms, of deploying vaccines against outbreaks of some of the deadliest infectious diseases. "This study demonstrates clearly the power of vaccines as a cost-effective counter-measure to the increasing risk the world faces from outbreaks. "It also underscores the importance of fully funding Gavi, so it can continue to protect communities in the next five years to come." Gavi is currently trying to secure a fresh round of funding in the face of global cuts to foreign aid. Agencies
